|
EP3650066A1
|
|
Inhaler jacket with cap attachment
|
|
GB201520862D0
|
|
Pharmaceutical composition
|
|
GB201515310D0
|
|
Pharmaceutical composition
|
|
GB201419257D0
|
|
Pharmaceutical compositions
|
|
AU2013245435A1
|
|
Method and apparatus for producing a centred compression coated tablet
|
|
AU2013203244A1
|
|
Improved formulations
|
|
AU2013202344A1
|
|
Controlled release oral dosage formulations comprising a core and one or more barrier layers
|
|
AU2013201966A1
|
|
Method and apparatus for producing a centred compression coated tablet
|
|
AU2013201071A1
|
|
Improved medicinal aerosol formulations
|
|
GB201218012D0
|
|
Dosage forms
|
|
GB201207886D0
|
|
Improvements in or relating to organic compounds
|
|
GB201206649D0
|
|
Improvments in or relating to organic compounds
|
|
GB201118193D0
|
|
Improvements in or relating to oranic compounds
|
|
GB201118181D0
|
|
Pharmaceutical compositions
|
|
GB201118198D0
|
|
Improvements in or relating to organic compounds
|
|
GB201118182D0
|
|
Improvements in or relating to organic compounds
|
|
AU2011232809A1
|
|
Tablets with site and time-controlled gastrointestinal release of active ingredient
|
|
EP2590633A1
|
|
Dosage form
|
|
GB201109214D0
|
|
Pharmaceutical composition comprising dronedarone hydrochloride that exhibits a reduced food effect
|
|
GB201018917D0
|
|
Dosage form
|
